Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

OTC Awards

Roche Basel Switzerland

Hemlibra off to a flyer as Roche raises 2019 forecasts

Drug has made almost as much in this quarter as it did in 2018

- PMLiVE

Gilead drives NASH development with insitro collaboration

Announcement comes days after Novo Nordisk deal

- PMLiVE

Akcea steals march on Alnylam with NICE approval

Advantage to Tegsedi over Onpattro

- PMLiVE

Catalent preps for complex therapy boom with $1.2bn Paragon buy

Reflects growing investment in cell and gene therapies

- PMLiVE

First-in-class hepatitis B/D drug raises cure hope

Those taking the regimen saw virus levels decline

- PMLiVE

Chi-Med goes for third IPO in Hong Kong

New listing follows first product launch

Cuttsy+Cuttsy awarded IPA Platinum

Cuttsy+Cuttsy awarded CPD Platinum by the IPA

Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation.

Cuttsy + Cuttsy

- PMLiVE

Breaking Bad

Six behaviours separate the good brand teams from the bad

- PMLiVE

The first, my last, my everything

The inescapable rise of patient-centricity

- PMLiVE

J&J’s Invokana first SGLT2 to show kidney disease benefits

Could help revival after amputation risk scare

- PMLiVE

J&J’s targeted bladder cancer treatment gets US approval

Balversa is first FGFR inhibitor

- PMLiVE

Allergan wins support against dissident shareholders

Shareholders vote on 1 May

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links